Pharmaceutical Technology
November 02, 2004
Articles
28
11
Amid the finger-pointing, hand-wringing, and bloviating, the supply of hard, technical information remains frustratingly small.
November 02, 2004
Articles
28
11
This article provides guidance for minimally acceptable method validation practices and a foundation for assessing the risks and benefits associated with method validation programs.
November 02, 2004
Articles
28
11
A discussion of the validation and operation of two commercially available vapor-phase hydrogen peroxide decontamination systems is presented, based on a hands-on examination of both systems.
November 02, 2004
Articles
28
11
Pharmaceutical Science & Technology Innovations
November 02, 2004
Articles
28
11
What should pharmaceutical companies make of recent corporate developments at several high-profile service providers?
November 02, 2004
Articles
28
11
With creative engineering and sophisticated chemistry, industry scientists offer big solutions for attaining small particle sizes and narrow distributions.
November 02, 2004
Articles
28
11
Phase II of FDA's GMP modernization plan may involve revising regulations to fit new policies and inspection and review programs.